A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age

BACKGROUND: The 21-gene recurrence score (RS) testing can predict the prognosis for luminal breast cancer patients. Meanwhile, patients > 50 years with RS > 25 have improved survival with adjuvant chemotherapy. The current study aimed to develop a nomogram with routine parameters to predict RS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jing, Wu, Jiayi, Huang, Ou, He, Jianrong, Zhu, Li, Chen, Weiguo, Li, Yafen, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885620/
https://www.ncbi.nlm.nih.gov/pubmed/33593381
http://dx.doi.org/10.1186/s12967-021-02743-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885620/
https://www.ncbi.nlm.nih.gov/pubmed/33593381
http://dx.doi.org/10.1186/s12967-021-02743-3

Ejemplares similares